German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0

ESMO Gastrointestinal Oncology Pub Date : 2025-01-06 DOI:10.1016/j.esmogo.2024.100112

M.P. Ebert , W. Fischbach , S. Hollerbach , J. Höppner , D. Lorenz , M. Stahl , M. Stuschke , O. Pech , U. Vanhoefer , C. Bruns , C. Ell , M. Follmann , U. Goerling , L. Grenacher , J. Haardt , A.H. Hölscher , R. Hummel , W.T. Knoefel , J. Körber , R. Langer , R. Porschen

{"title":"German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0","authors":"M.P. Ebert , W. Fischbach , S. Hollerbach , J. Höppner , D. Lorenz , M. Stahl , M. Stuschke , O. Pech , U. Vanhoefer , C. Bruns , C. Ell , M. Follmann , U. Goerling , L. Grenacher , J. Haardt , A.H. Hölscher , R. Hummel , W.T. Knoefel , J. Körber , R. Langer , R. Porschen","doi":"10.1016/j.esmogo.2024.100112","DOIUrl":null,"url":null,"abstract":"<div><div>This guideline for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus was developed and managed by the German Guideline Program in Oncology (GGPO) of the Association of the Scientific Medical Societies in Germany (AWMF), German Cancer Society (DKG), and German Cancer Aid (DKH). The guideline commission comprised multidisciplinary experts from various professional associations and organizations involved in the management of esophageal cancer, as well as a patient representative. Quality of the evidence is presented using Oxford evidence-based medicine system, and recommendations were graded in a formal consensus process using a recommendation grading scheme.</div></div>","PeriodicalId":100490,"journal":{"name":"ESMO Gastrointestinal Oncology","volume":"7 ","pages":"Article 100112"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Gastrointestinal Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949819824000736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

This guideline for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus was developed and managed by the German Guideline Program in Oncology (GGPO) of the Association of the Scientific Medical Societies in Germany (AWMF), German Cancer Society (DKG), and German Cancer Aid (DKH). The guideline commission comprised multidisciplinary experts from various professional associations and organizations involved in the management of esophageal cancer, as well as a patient representative. Quality of the evidence is presented using Oxford evidence-based medicine system, and recommendations were graded in a formal consensus process using a recommendation grading scheme.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

ESMO Gastrointestinal Oncology

自引率

0.00%

发文量